|
Showing the most relevant articles for your search:AMEX:ANX | Date | Time | Source | Headline | Symbol | Company | | 06/25/2008 | 9:02AM | Edgar (US Regulatory) | Adventrx Pharmaceuticals Inc - Securities Registration: Employee Benefit Plan (S-8) | AMEX:ANX | Mast Therapeutics, Inc. |
| 06/16/2008 | 6:00AM | PR Newswire (US) | ADVENTRX Announces CoFactor(R) Phase 2b Clinical Trial Overall Survival Results | AMEX:ANX | Mast Therapeutics, Inc. |
| 06/05/2008 | 2:28PM | Edgar (US Regulatory) | Adventrx Pharmaceuticals Inc - Initial Statement of Beneficial Ownership (3) | AMEX:ANX | Mast Therapeutics, Inc. |
| 06/03/2008 | 6:03AM | Edgar (US Regulatory) | Adventrx Pharmaceuticals Inc - Current report filing (8-K) | AMEX:ANX | Mast Therapeutics, Inc. |
| 06/03/2008 | 7:00AM | PR Newswire (US) | ADVENTRX Presents CoFactor Data at the 2008 Annual Meeting of the American Society of Clinical Oncology (ASCO) | AMEX:ANX | Mast Therapeutics, Inc. |
| 06/02/2008 | 5:06PM | Edgar (US Regulatory) | Adventrx Pharmaceuticals Inc - Current report filing (8-K) | AMEX:ANX | Mast Therapeutics, Inc. |
| 05/20/2008 | 8:01AM | Edgar (US Regulatory) | Adventrx Pharmaceuticals Inc - Current report filing (8-K) | AMEX:ANX | Mast Therapeutics, Inc. |
| 05/16/2008 | 1:14PM | Edgar (US Regulatory) | Adventrx Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4) | AMEX:ANX | Mast Therapeutics, Inc. |
| 05/16/2008 | 6:00AM | PR Newswire (US) | ADVENTRX Announces ANX-530 Safety Data From Registrational Bioequivalence Clinical Study | AMEX:ANX | Mast Therapeutics, Inc. |
| 05/13/2008 | 6:00AM | PR Newswire (US) | ADVENTRX Pharmaceuticals to Present at the Rodman & Renshaw 5th Annual Global Healthcare Conference | AMEX:ANX | Mast Therapeutics, Inc. |
| 05/12/2008 | 6:31AM | Edgar (US Regulatory) | Adventrx Pharmaceuticals Inc - Quarterly Report (10-Q) | AMEX:ANX | Mast Therapeutics, Inc. |
| 05/12/2008 | 6:07AM | Edgar (US Regulatory) | Adventrx Pharmaceuticals Inc - Current report filing (8-K) | AMEX:ANX | Mast Therapeutics, Inc. |
| 05/12/2008 | 6:00AM | PR Newswire (US) | ADVENTRX Pharmaceuticals Reports First Quarter 2008 Financial Results | AMEX:ANX | Mast Therapeutics, Inc. |
| 05/05/2008 | 6:00AM | PR Newswire (US) | ADVENTRX Pharmaceuticals to Report First Quarter 2008 Results | AMEX:ANX | Mast Therapeutics, Inc. |
| 04/29/2008 | 10:02AM | Edgar (US Regulatory) | Adventrx Pharmaceuticals Inc - Current report filing (8-K) | AMEX:ANX | Mast Therapeutics, Inc. |
| 04/16/2008 | 5:16PM | Edgar (US Regulatory) | Adventrx Pharmaceuticals Inc - Current report filing (8-K) | AMEX:ANX | Mast Therapeutics, Inc. |
| 04/16/2008 | 4:07PM | Edgar (US Regulatory) | Adventrx Pharmaceuticals Inc - Proxy Statement (definitive) (DEF 14A) | AMEX:ANX | Mast Therapeutics, Inc. |
| 04/15/2008 | 5:15PM | Edgar (US Regulatory) | Adventrx Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4) | AMEX:ANX | Mast Therapeutics, Inc. |
| 04/15/2008 | 5:13PM | Edgar (US Regulatory) | Adventrx Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4) | AMEX:ANX | Mast Therapeutics, Inc. |
| 04/15/2008 | 5:12PM | Edgar (US Regulatory) | Adventrx Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4) | AMEX:ANX | Mast Therapeutics, Inc. |
| 04/15/2008 | 5:09PM | Edgar (US Regulatory) | Adventrx Pharmaceuticals Inc - Amended Statement of Beneficial Ownership (3/A) | AMEX:ANX | Mast Therapeutics, Inc. |
| 04/15/2008 | 7:00AM | PR Newswire (US) | ANX-530 Demonstrates Equivalent Pharmacokinetics to Navelbine(R) in a Registrational Bioequivalence Clinical Study | AMEX:ANX | Mast Therapeutics, Inc. |
| 04/09/2008 | 6:00AM | PR Newswire (US) | ADVENTRX Appoints Vice President of Manufacturing | AMEX:ANX | Mast Therapeutics, Inc. |
| 04/07/2008 | 3:56PM | Edgar (US Regulatory) | Adventrx Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4) | AMEX:ANX | Mast Therapeutics, Inc. |
| 04/04/2008 | 3:03PM | Edgar (US Regulatory) | Adventrx Pharmaceuticals Inc - Current report filing (8-K) | AMEX:ANX | Mast Therapeutics, Inc. |
| 04/03/2008 | 3:00PM | PR Newswire (US) | ADVENTRX Creates Executive Vice President Position and Announces New Chief Financial Officer | AMEX:ANX | Mast Therapeutics, Inc. |
| 03/31/2008 | 6:00AM | PR Newswire (US) | ANX-201 Demonstrates a Unique Resistance Profile in Preclinical Tests | AMEX:ANX | Mast Therapeutics, Inc. |
| 03/26/2008 | 12:26PM | Edgar (US Regulatory) | Adventrx Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4) | AMEX:ANX | Mast Therapeutics, Inc. |
| 03/25/2008 | 4:08PM | Edgar (US Regulatory) | Adventrx Pharmaceuticals Inc - Current report filing (8-K) | AMEX:ANX | Mast Therapeutics, Inc. |
| 03/25/2008 | 3:27PM | Edgar (US Regulatory) | Adventrx Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4) | AMEX:ANX | Mast Therapeutics, Inc. |
|
Showing the most relevant articles for your search:AMEX:ANX |
|